MTAP deletion marks poorer survival in pancreatic cancer cohort
A retrospective US cohort of 2,694 pancreatic cancer patients found MTAP deletion in 30.5 percent of tumors and consistently lower ...
Tag: PRMT5 inhibitors
POPULAR NEWS
-
Inflammation-Weighted Nutrition Score Predicts Survival After Liver Cancer Surgery
-
RAS Inhibitor Daraxonrasib Redefines Pancreatic Cancer Treatment After FDA Approval
-
Few Ethiopian Mothers Receive Quality Care Across Maternity Continuum
-
Particle Swarm Optimization Steers Client Selection in Decentralized Federated Learning